Stay updated on Cabozantinib And Androgen Ablation in Prostate Cancer Clinical Trial
Sign up to get notified when there's something new on the Cabozantinib And Androgen Ablation in Prostate Cancer Clinical Trial page.

Latest updates to the Cabozantinib And Androgen Ablation in Prostate Cancer Clinical Trial page
- Check4 days agoNo Change Detected
- Check12 days agoChange DetectedProstate cancer and related topics (MedlinePlus Genetics) were removed, and a new Revision: v3.4.2 tag was added.SummaryDifference0.2%

- Check19 days agoChange DetectedAdded Prostate cancer topic and MedlinePlus Genetics related topics, and updated revision from v3.4.0 to v3.4.1.SummaryDifference0.2%

- Check27 days agoChange DetectedRelated topics 'Prostate cancer' and 'MedlinePlus Genetics' were removed from the page's related topics section. The main study content remains available.SummaryDifference0.2%

- Check34 days agoChange DetectedRemoval of Prostate Cancer, related topics, and MedlinePlus Genetics sections/links from the page.SummaryDifference0.2%

- Check41 days agoChange DetectedAdded 'Prostate cancer' topic and related topic 'MedlinePlus Genetics'; page revision updated from v3.3.3 to v3.3.4.SummaryDifference0.2%

- Check63 days agoChange DetectedAdded a Locations section with Texas as a study site and updated the revision to v3.3.3. Removed the HHS Vulnerability Disclosure and the Texas Locations item.SummaryDifference0.2%

Stay in the know with updates to Cabozantinib And Androgen Ablation in Prostate Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Cabozantinib And Androgen Ablation in Prostate Cancer Clinical Trial page.